The pharmaceutical industry has suggested to the central government that it should increase its reviewing powers on the decisions taken…

The growing reports of child deaths from different parts of the country since last summer’s Gorakhpur tragedy have finally put…

Domestic pharmaceutical companies are now focusing on the over-the-counter (OTC) segment to accelerate sales growth. They are relaunching older prescription…

After a major slowdown, new drug approvals are likely to pick up after the National Pharmaceutical Pricing Authority (NPPA) decided…

Audits of Indian drug manufacturing facilities by the Food and Drug Administration are set to rise sharply after October’s Mutual…